Is preemptive therapy for CMV infection following liver transplantation superior to symptom-triggered treatment? [electronic resource]
Producer: 20010628Description: 1804 p. digitalISSN:- 0041-1345
- Administration, Oral
- Antigens, Viral -- blood
- Antiviral Agents -- administration & dosage
- Biomarkers -- blood
- Case-Control Studies
- Cytomegalovirus Infections -- drug therapy
- Female
- Ganciclovir -- administration & dosage
- Humans
- Liver Transplantation -- immunology
- Male
- Middle Aged
- Phosphoproteins -- blood
- Prospective Studies
- Viral Matrix Proteins -- blood
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.